Strain specific effects of cytomegalovirus on endothelial cells: Implications for investigating the relationship between CMV and cardiac allograft vasculopathy

Transplantation

Volumn 68, Issue 10, 1999, Pages 1568-1573

  Srivastava, Rohit ^a   Curtis, Michelle ^a   Hendrickson, Sara ^a   Burns, William H ^a   Hosenpud, Jeffrey D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR A; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VIRUS GENOME;

EID: 0033610644     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199911270-00022     Document Type: Article

References (29)

1. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261(24): 3561.
2. Weimar W, Balk AH, Metselaar HJ, Mochtar B, Rothbarth PH. On the relation between cytomegalovirus infection and rejection after heart transplantation. Transplantation 1991; (1):162.
3. Koskinen PK, Nieminen MS, Krogerus LA, et al. Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial biopsy findings in heart transplant patients. Transplant Int 1993; 6 (6): 341.
4. Loebe M, Schuler S, Zais O, Warnecke H, Fleck E, Hetzer R. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant 1990; 9 (6): 707.
5. McDonald K, Rector TS, Braulin EA, Kubo SH, Olivari MT. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989; 64 (5): 359.
6. Elek SD, Stern H. Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero. Lancet 1974; 1: 1.
7. Plotnik SA, Farquhar J, Hornberger E. Clinical trials of immunizationwith towne 125 strain of human cytomegalovirus. J Infect Dis 1976; 134: 470.
8. Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 1996; 70 (1): 78.
9. Smiley ML, Mar EC, Huang ES. Cytomegalovirus infection and virus-induced transformation of human endothelial cells. J Med Virol 1988; 56: 213.
10. Woodroffe SB, Hamilton J, Garnett HM. Comparison of the infectivity of the laboratory strain AD169 and a clinical isolate of human cytomegalovirus to human smooth muscle cells. J Virol Methods 1997; 63 (1-2): 181.
11. Hosenpud JD, Chou SW, Wagner CR. Cytomegalovirus-induced regulation of major histo-compatibility complex class I antigen expression in human aortic smooth muscle cells. Transplantation 1991; 52 (5): 896.
12. van Dorp WT, Jonges E, Bruggeman CA, Daha MR, van Es LA, van Der Woude FJ. Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection.Transplantation 1989; 48 (3): 469.
13. Sedmak DD, Roberts WH, Stephens RE, et al. Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigen expression. Transplantation 1990; 49 (2): 458.
14. Scholz M, Hamann A, Blaheta RA, Auth MK, Encke A, Markus BH. Cytomegalovirus- and interferon-related effects on human endothelial cells. Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-gamma. Hum Immunol 1992; 35 (4): 230.
15. Uretsky BF, Murali S, Reddy PS, Rabin B, Lee A, Griffith BP, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987; 76 (4): 827.
16. Oni AA, Ray J, Hosenpud JD. Coronary venous intimal thickening in explanted cardiac allografts. Evidence demonstrating that transplant coronary artery disease is a manifestation of a diffuse allograft vasculopathy. Transplantation 1992; 53 (6): 1247.
17. Salomon RN, Hughes CC, Schoen FJ, Payne DD, Pober JS, Libby P. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol 1991; 138 (4): 791.
18. Libby P, Salomon RN, Payne DD, Schoen FJ, Pober JS. Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant Proc 1989; 21 (4): 3677.
19. Wagner CR, Morris TE, Shipley GD, Hosenpud JD. Regulation of human aortic endothelial cell-derived mesenchymal growth factors by allogeneic lymphocytes in vitro. A potential mechanism for cardiac allograft vasculopathy. J Clin Invest 1993; 92 (3): 1269.
20. Hosenpud JD, Morris TE, Shipley GD, Mauck KA, Wagner CR. Cardiac allograft vasculopathy. Preferential regulation of endothelial cell-derived mesenchymal growth factors in response to a donor-specific cell-mediated allogeneic response. Transplantation 1996; Mar 27: 61 (6): 939.
21. Isik FF, Valentine HA, McDonald TO, Baird A, Gordon D. Localization of bFGF in human transplant coronary atherosclerosis. Ann NY Acad Sci 1991; 638: 487.
22. Zhao XM, Yeoh TK, Frist WH, Porterfield DL, Miller GG. Induction of acidic fibroblast growth factor and full-length platelet-derived growth factor expression in human cardiac allografts. Analysis by PCR. in situ hybridization, and immunohistochemistry. Circulation 1994; 90: 677.
23. Fealy MJ, Most D, Huie P, et al. Association of down-regulation of cytokine activity with rat hind limb allograft survival. Transplantation 1995; 59 (10): 1475.
24. Lemstrom KB, Aho PT, Bruggeman CA, Hayry PJ. Cytomegalovirus infection enhances mRXA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis. Arterioscler Thromb 1994; 14 (12): 2043.
25. Shaddy RE, Hammond EH, Yowell RL. Immunohistochemical analysis of platelet-derived growth factor and basic fibroblast growth factor in cardiac biopsy and autopsy specimens of heart transplant patients. Am J Cardiol 1996; 77 (14): 1210.
26. Ustinov JA, Loginov RJ, Bruggeman CA, van der Meide PH, Hayry PJ, Lautenschlager IT. Cytomegalovirus induces class II expression in rat heart endothelial cells. J Heart Lung Transplant 1993; 12 (4): 644.
27. Sedmak DD, Roberts WH, Stephens RE, et al. Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigen expression. Transplantation 1990; 49 (2): 458.
28. Sedmak DD, Guglielmo Am, Knight DA, Birmingham DJ, Huang EH, Waldman WJ. Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am J Pathol 1994; 144 (4): 683.
29. Arkonac B, Mauck KA, Chou S, Hosenpud JD. Low multiplicity cytomegalovirus infection of human aortic smooth muscle cells increases levels of major histocompatibility complex class I antigens and induces a proinflammatory cytokine milieu in the absence of cytopathology. J Heart Lung Transplant 1997; 16 (10):1035.